Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Are Pfizer and Moderna Stocks Buys With a Potential COVID Surge Coming?


COVID-19 hasn't gone away. But a quick look at the charts of Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) stocks will tell you that the coronavirus isn't as big of a concern as it used to be.

The situation could change in the near future, though. Some scientists believe the evidence is pointing to the likelihood of yet another COVID-19 wave in the fall and winter. In particular, they're tracking new coronavirus variants. Are Pfizer and Moderna stocks buys right now with a potential COVID-19 surge on the way?

We must address two key questions to get a feel for how these vaccine stocks are likely to perform going into 2023. First, how bad might the next coronavirus outbreak be? Second, how much impact might another COVID-19 wave have on vaccine sales for Pfizer and Moderna? Unfortunately, no one knows for sure what the answer is to either question.

Continue reading


Source Fool.com

Like: 0
Share

Comments